Liotta LA - Search Results

1

Use of proteomic analysis to monitor responses to biological therapies.

Espina V, Dettloff KA, Cowherd S, Petricoin EF 3rd, Liotta LA. Espina V, et al. Among authors: liotta la. Expert Opin Biol Ther. 2004 Jan;4(1):83-93. doi: 10.1517/14712598.4.1.83. Expert Opin Biol Ther. 2004. PMID: 14680471 Review.

2

Protein microarrays: molecular profiling technologies for clinical specimens.

Espina V, Mehta AI, Winters ME, Calvert V, Wulfkuhle J, Petricoin EF 3rd, Liotta LA. Espina V, et al. Among authors: liotta la. Proteomics. 2003 Nov;3(11):2091-100. doi: 10.1002/pmic.200300592. Proteomics. 2003. PMID: 14595807 Review.

3

Proteomic approaches in cancer risk and response assessment.

Petricoin EF, Liotta LA. Petricoin EF, et al. Among authors: liotta la. Trends Mol Med. 2004 Feb;10(2):59-64. doi: 10.1016/j.molmed.2003.12.006. Trends Mol Med. 2004. PMID: 15102358 Review.

4

SELDI-TOF-based serum proteomic pattern diagnostics for early detection of cancer.

Petricoin EF, Liotta LA. Petricoin EF, et al. Among authors: liotta la. Curr Opin Biotechnol. 2004 Feb;15(1):24-30. doi: 10.1016/j.copbio.2004.01.005. Curr Opin Biotechnol. 2004. PMID: 15102462

5

Protein microarray detection strategies: focus on direct detection technologies.

Espina V, Woodhouse EC, Wulfkuhle J, Asmussen HD, Petricoin EF 3rd, Liotta LA. Espina V, et al. Among authors: liotta la. J Immunol Methods. 2004 Jul;290(1-2):121-33. doi: 10.1016/j.jim.2004.04.013. J Immunol Methods. 2004. PMID: 15261576 Review.

6

Proteomic analysis of human breast cancer tissue with laser-capture microdissection and reverse-phase protein microarrays.

Cowherd SM, Espina VA, Petricoin EF 3rd, Liotta LA. Cowherd SM, et al. Among authors: liotta la. Clin Breast Cancer. 2004 Dec;5(5):385-92. doi: 10.3816/cbc.2004.n.046. Clin Breast Cancer. 2004. PMID: 15585078 Review.

7

Clinical proteomics: from biomarker discovery and cell signaling profiles to individualized personal therapy.

Calvo KR, Liotta LA, Petricoin EF. Calvo KR, et al. Among authors: liotta la. Biosci Rep. 2005 Feb-Apr;25(1-2):107-25. doi: 10.1007/s10540-005-2851-3. Biosci Rep. 2005. PMID: 16222423 Review.

8

Clinical potential of proteomics in the diagnosis of ovarian cancer.

Ardekani AM, Liotta LA, Petricoin EF 3rd. Ardekani AM, et al. Among authors: liotta la. Expert Rev Mol Diagn. 2002 Jul;2(4):312-20. doi: 10.1586/14737159.2.4.312. Expert Rev Mol Diagn. 2002. PMID: 12138495 Review.

9

Proteomic technologies to study diseases of the lymphatic vascular system.

Leak LV, Petricoin EF 3rd, Jones M, Paweletz CP, Ardekani AM, Fusaro VA, Ross S, Liotta LA. Leak LV, et al. Among authors: liotta la. Ann N Y Acad Sci. 2002 Dec;979:211-28; discussion 229-34. doi: 10.1111/j.1749-6632.2002.tb04881.x. Ann N Y Acad Sci. 2002. PMID: 12543730 Review.

10

Proteomic analysis at the bedside: early detection of cancer.

Petricoin EF, Liotta LA. Petricoin EF, et al. Among authors: liotta la. Trends Biotechnol. 2002 Dec;20(12 Suppl):S30-4. doi: 10.1016/s1471-1931(02)00204-5. Trends Biotechnol. 2002. PMID: 12570157 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

691 results

Search Page

Filters